Inactive Instrument

Remedent, Inc. Stock Other OTC

Equities

REMI

US75954T1043

Medical Equipment, Supplies & Distribution

Sales 2022 402K Sales 2023 46.11K Capitalization 3.07M
Net income 2022 - Net income 2023 - EV / Sales 2022 7.44 x
Net cash position 2022 2.52K Net cash position 2023 27.69K EV / Sales 2023 65.9 x
P/E ratio 2022 *
-
P/E ratio 2023
-
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 61.46%
More Fundamentals * Assessed data
Dynamic Chart
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Remedent Announces Agreement with Aurum Ceramic Dental Laboratories Co., Concerning an Exclusive Master License Agreement in Reference to Its Glamsmile Veneers and Technology CI
Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Remedent, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Remedent, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2020 CI
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2020 CI
Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2019 CI
Remedent, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2019 CI
Remedent, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2019 CI
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2019 CI
Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2018 CI
Remedent, Inc Reports Financial Results for the First Quarter Ended June 30, 2017 CI
Remedent Enters into an Agreement with Condor Technologies NV CI
Remedent Enters into an Agreement in Relation to a Settlement of Secured Debt Extended by Excelsior and Asia Best Healthcare Co CI
More news
Managers TitleAgeSince
Chief Executive Officer 69 02-03-31
Director of Finance/CFO 59 05-03-29
Members of the board TitleAgeSince
Director/Board Member 81 02-03-31
Chief Executive Officer 69 02-03-31
Director of Finance/CFO 59 05-03-29
More insiders
Remedent, Inc. specializes in the research, development and manufacturing of oral care and cosmetic dentistry products. The Company designs, develops, manufactures and distributes its cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, Middle East and the United States. The Company's operating segment consists of dental products and oral hygiene products sold by Remedent Inc., Remedent N.V., and Biotech Dental Benelux N.V. The Company offers over-the-counter (OTC) tooth whitening products. It has three primary products: River 8, a prefabricated veneer; its custom-made GlamSmile Veneers and the SmileMe mirror. The Company has developed a range of prefabricated, ready-to-use veneers that the Company has branded as River8. The Company's product in the professional oral care and cosmetic dentistry is the GlamSmile veneer. The SmileMe Mirror enables the dentist to offer patients a complete Smile Consultation.
More about the company